课题基金 / 基金详情

A PHASE I OPEN LABEL SAFETY AND PHARMACOKINETIC STUDY OF SGT-53

A PHASE I OPEN LABEL SAFETY AND PHARMACOKINETIC STUDY OF SGT-53
SGT-53 的 I 期开放标签安全性和药代动力学研究
批准号:
7719057
负责人:
JOHN L. MARSHALL
金额:
$0.14万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-04-01 至 2009-03-31

项目摘要

项目成果

JOHN L. MARSHALL的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The primary objective of this study is to evaluate the safety of escalating doses of SGT-53 administered over a course of 5 weeks. Safety will be assessed by analysis of adverse experiences, clinical laboratory tests, and physical examinations.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CLINICAL TRIAL: PHASE 1 CLINICAL TRIAL OF DAILY ORAL GLEEVE AND ONE HOUR WEEKLY
  • 批准号:
    7951970
  • 项目类别:
  • 资助金额:
    $2.42万
  • 财政年份:
    2009
  • 负责人:
    JOHN L. MARSHALL
  • 依托单位:
CLINICAL TRIAL: PHASE 1 CLINICAL TRIAL OF DAILY ORAL GLEEVE AND ONE HOUR WEEKLY
  • 批准号:
    7719032
  • 项目类别:
  • 资助金额:
    $9.92万
  • 财政年份:
    2008
  • 负责人:
    JOHN L. MARSHALL
  • 依托单位:
VACCINIA-CEA(6D)TRICOM & FOWLPOX-CEA(6D)-TAXOTERE W/GM-CSF & DOCETAXEL
  • 批准号:
    7608454
  • 项目类别:
  • 资助金额:
    $10.51万
  • 财政年份:
    2007
  • 负责人:
    JOHN L. MARSHALL
  • 依托单位:
PH I: ORAL GLEEVEC & ONE HR WEEKLY PACLITAXEL INFUSION- METASTATICS SOLID TUMORS
  • 批准号:
    7608455
  • 项目类别:
  • 资助金额:
    $5.25万
  • 财政年份:
    2007
  • 负责人:
    JOHN L. MARSHALL
  • 依托单位:
国内基金
海外基金
Molecular Interaction Reconstruction of Rheumatoid Arthritis Therapies Using Clinical Data